Status:
RECRUITING
Interest of Auriculotherapy in the Treatment of Xerostomia
Lead Sponsor:
Hopital Foch
Conditions:
Xerostomia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia
Eligibility Criteria
Inclusion Criteria:
- Patients over 18 years old;
- Complain about xerostomia after cervical irradiation in the context of ENT cancer;
- End of radiotherapy> 3 months
- Covered by a national healthcare insurance
- Consent form signed.
Non inclusion Criteria:
- Pregnant or breastfeeding women;
- Local counterindication to auriculotherapy;
- With anticoagulant treatment;
- History or existing of hemophilia;
- Valvular prosthesis;
- Ear's pavilion infection;
- Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
- Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management);
- Difficulty to comply with the treatment, questionnaires or study protocol;
- Being deprived of liberty or under guardianship.
Key Trial Info
Start Date :
December 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 4 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04222478
Start Date
December 4 2019
End Date
December 4 2025
Last Update
February 12 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan
Brest, Brittany Region, France, 29600
2
Hôpital Forcilles
Férolles-Attilly, France, 77150
3
GHP Saint Joseph
Paris, France, 75014
4
Hôpital Foch
Suresnes, France, 92150